by eecpforum » Fri Dec 04, 2009 12:33 pm
MVP is not a contraindication for EECP therapy. If a patient has clinically significant heart valve disease, particluarly of the aortic valve, this can be a treatment precaution depending on the degree of regurgitation or backflow of blood that might be going on. Many patients with MVP have no clinically significant mitral regurgitation. It is a good idea to have an echocardiogram performed recently before initiating EECP therapy to evaluate overall heart function.
Tom Riedman, RN
Manager of Clinical Affairs
Vasomedical, Inc.